Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

VRTX Insider Trading (Vertex Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.40%

Insider Buying (Last 12 Months): $1,956,500.00

Insider Selling (Last 12 Months): $18,085,510.14

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$287.32

▲ +5.53 (1.96%)

As of 07/1/2022 04:59 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/24/2022	Reshma Kewalramani	CEO	Sell	11,689	$291.30	$3,405,005.70	111,153
5/4/2022	Bastiano Sanna	EVP	Sell	36	$275.09	$9,903.24	41,660
5/2/2022	Bastiano Sanna	EVP	Sell	320	$259.16	$82,931.20	41,696
5/2/2022	Charles F. Wagner, Jr.	CFO	Sell	343	$258.83	$88,778.69	42,730
5/2/2022	Sangeeta N Bhatia	Director	Sell	737	$258.94	$190,838.78	5,903
5/2/2022	Stuart A. Arbuckle	COO	Sell	306	$263.98	$80,777.88	64,760
4/29/2022	Joy Liu	SVP	Sell	120	$275.41	$33,049.20	14,334
4/25/2022	Kristen Ambrose	CAO	Sell	327	$269.55	$88,142.85	3,496
4/18/2022	Yuchun Lee	Director	Sell	2,000	$284.23	$568,460.00	1,875
4/13/2022	Jeffrey M. Leiden	Chairman	Sell	15,789	$289.04	$4,563,652.56	74,160
4/13/2022	Yuchun Lee	Director	Sell	2,000	$287.50	$575,000.00	1,875
4/11/2022	Yuchun Lee	Director	Sell	2,000	$280.30	$560,600.00	1,875
4/7/2022	Bastiano Sanna	EVP	Sell	561	$276.18	$154,936.98	42,782
4/7/2022	Yuchun Lee	Director	Sell	2,000	$274.86	$549,720.00	1,099
4/4/2022	Bastiano Sanna	EVP	Sell	562	$267.71	$150,453.02	43,343
4/4/2022	Yuchun Lee	Director	Sell	2,000	$267.72	$535,440.00	1,875
4/1/2022	Charles F. Wagner, Jr.	CFO	Sell	2,582	$264.76	$683,610.32	43,620
3/31/2022	Margaret G. McGlynn	Director	Sell	5,000	$262.27	$1,311,350.00	1,099
3/17/2022	Charles F. Wagner, Jr.	CFO	Sell	3,171	$250.15	$793,225.65
3/17/2022	Ourania Tatsis	EVP	Sell	2,833	$250.11	$708,561.63
2/25/2022	Ourania Tatsis	EVP	Sell	325	$230.95	$75,058.75
2/18/2022	Ourania Tatsis	EVP	Sell	519	$231.00	$119,889.00
2/11/2022	David Altshuler	EVP	Sell	2,297	$235.02	$539,840.94
2/2/2022	Bastiano Sanna	EVP	Sell	1,040	$250.98	$261,019.20
2/2/2022	Charles F. Wagner, Jr.	CFO	Sell	2,944	$250.07	$736,206.08
1/28/2022	Margaret G. McGlynn	Director	Sell	5,000	$241.79	$1,208,950.00
11/15/2021	Amit Sachdev	EVP	Sell	51	$187.19	$9,546.69
11/15/2021	Stuart A. Arbuckle	COO	Sell	3	$187.26	$561.78
8/19/2021	Reshma Kewalramani	CEO	Buy	10,000	$195.65	$1,956,500.00	69,511
6/2/2021	Sangeeta N. Bhatia	Director	Sell	559	$209.69	$117,216.71	5,465
5/3/2021	Bastiano Sanna	EVP	Sell	960	$218.43	$209,692.80	35,068
4/27/2021	Amit Sachdev	EVP	Sell	3,884	$216.06	$839,177.04	44,017
4/5/2021	Bastiano Sanna	EVP	Sell	1,686	$214.14	$361,040.04	36,223
2/11/2021	Bastiano Sanna	EVP	Sell	1,686	$210.56	$355,004.16	39,081
2/11/2021	Paul M. Silva	CAO	Sell	1,498	$210.57	$315,433.86	24,073
2/5/2021	Michael Parini	EVP	Sell	1,930	$215.00	$414,950.00	59,157
2/3/2021	Michael Parini	EVP	Sell	400	$216.56	$86,624.00	35,276
11/10/2020	Bruce I. Sachs	Director	Buy	15,000	$217.36	$3,260,400.00	18,035
11/3/2020	Stuart A. Arbuckle	EVP	Sell	1,553	$211.92	$329,111.76	36,732
10/5/2020	Sangeeta N Bhatia	Director	Sell	10,516	$266.79	$2,805,563.64	14,424
8/3/2020	Amit Sachdev	EVP	Sell	1,941	$278.28	$540,141.48	37,044
7/13/2020	Michael Parini	EVP	Sell	2,125	$292.05	$620,606.25	28,963
7/13/2020	Paul M. Silva	SVP	Sell	860	$292.03	$251,145.80	15,792
7/10/2020	Charles F. Wagner, Jr.	CFO	Sell	700	$293.15	$205,205.00	16,786
7/7/2020	Stuart A. Arbuckle	EVP	Sell	2,786	$300.00	$835,800.00	36,743
6/30/2020	Jeffrey M. Leiden	Chairman	Sell	32,792	$286.15	$9,383,430.80	29,252
5/12/2020	Jeffrey M. Leiden	Chairman	Sell	94,370	$283.47	$26,751,063.90	65,036
5/11/2020	Amit Sachdev	EVP	Sell	10,665	$282.61	$3,014,035.65	45,768
5/7/2020	Bruce I. Sachs	Director	Sell	45,000	$269.80	$12,141,000.00	33,710
5/6/2020	Paul M. Silva	SVP	Sell	1,076	$272.74	$293,468.24	15,397
5/5/2020	Amit Sachdev	EVP	Sell	13,356	$270.01	$3,606,253.56	67,603
5/5/2020	Jeffrey M. Leiden	Chairman	Sell	94,372	$269.94	$25,474,777.68	76,707
5/4/2020	Paul M. Silva	SVP	Sell	809	$260.87	$211,043.83	15,741
4/29/2020	Michael Parini	EVP	Sell	2,125	$254.95	$541,768.75	28,963
4/27/2020	Yuchun Lee	Director	Sell	2,000	$271.21	$542,420.00	3,875
4/24/2020	Yuchun Lee	Director	Sell	2,000	$268.14	$536,280.00	3,875
4/22/2020	Yuchun Lee	Director	Sell	2,000	$267.88	$535,760.00	3,875
4/20/2020	Yuchun Lee	Director	Sell	2,000	$273.16	$546,320.00	3,875
4/13/2020	Paul M. Silva	SVP	Sell	859	$248.72	$213,650.48	15,791
4/6/2020	Paul M. Silva	SVP	Sell	4,891	$255.57	$1,249,992.87	19,823
2/25/2020	Amit Sachdev	EVP	Sell	3,376	$233.53	$788,397.28	36,291
2/25/2020	Jeffrey M. Leiden	CEO	Sell	10,550	$233.46	$2,463,003.00	103,131
2/25/2020	Ourania Tatsis	SVP	Sell	1,296	$233.17	$302,188.32	14,034
2/25/2020	Reshma Kewalramani	CMO	Sell	3,634	$233.45	$848,357.30	30,260
2/18/2020	Amit Sachdev	EVP	Sell	3,489	$243.56	$849,780.84	42,936
2/18/2020	Jeffrey M. Leiden	CEO	Sell	11,685	$243.52	$2,845,531.20	123,226
2/18/2020	Ourania Tatsis	SVP	Sell	1,279	$243.62	$311,589.98	16,349
2/18/2020	Reshma Kewalramani	CMO	Sell	1,183	$243.51	$288,072.33	34,341
2/7/2020	Yuchun Lee	Director	Sell	2,000	$237.82	$475,640.00	3,875
2/4/2020	Yuchun Lee	Director	Sell	2,000	$238.84	$477,680.00	3,875
1/22/2020	Michael Parini	EVP	Sell	1	$237.50	$237.50	35,004
1/16/2020	Amit Sachdev	EVP	Sell	5,000	$235.00	$1,175,000.00	41,190
1/13/2020	Michael Parini	EVP	Sell	2,125	$226.78	$481,907.50	37,128
1/13/2020	Paul M. Silva	SVP	Sell	860	$229.38	$197,266.80	18,619
1/8/2020	Amit Sachdev	EVP	Sell	5,000	$230.00	$1,150,000.00	41,190
1/8/2020	Paul M. Silva	SVP	Sell	13,750	$231.89	$3,188,487.50	31,509
1/6/2020	Michael Parini	EVP	Sell	4,250	$222.00	$943,500.00	39,253
1/2/2020	Paul M. Silva	SVP	Sell	25,630	$218.92	$5,610,919.60	34,517
1/2/2020	William D Young	Director	Sell	20,000	$218.93	$4,378,600.00	29,311
12/9/2019	Amit Sachdev	EVP	Sell	5,000	$225.00	$1,125,000.00	38,416
11/25/2019	Amit Sachdev	EVP	Sell	5,000	$220.00	$1,100,000.00	38,416
11/25/2019	Reshma Kewalramani	CMO	Sell	4,692	$219.37	$1,029,284.04	17,790
11/19/2019	Amit Sachdev	EVP	Sell	5,000	$215.00	$1,075,000.00	38,416
11/18/2019	Jeffrey M. Leiden	CEO	Sell	9,434	$216.75	$2,044,819.50	170,378
11/13/2019	Michael Parini	EVP	Sell	4,892	$205.50	$1,005,306.00	39,895
11/13/2019	Ourania Tatsis	SVP	Sell	2,853	$205.59	$586,548.27	10,105
11/8/2019	Reshma Kewalramani	CMO	Sell	509	$199.00	$101,291.00	13,607
11/6/2019	David Altshuler	EVP	Sell	1,223	$197.21	$241,187.83	32,776
11/4/2019	Amit Sachdev	EVP	Sell	4,097	$200.34	$820,792.98	35,571
11/1/2019	Jeffrey M. Leiden	CEO	Sell	96,822	$200.02	$19,366,336.44	115,166
11/1/2019	Sangeeta N Bhatia	Director	Sell	1,291	$200.00	$258,200.00	6,540
10/30/2019	Reshma Kewalramani	CMO	Sell	3,057	$199.00	$608,343.00	16,155
10/25/2019	Amit Sachdev	EVP	Sell	4,311	$197.89	$853,103.79	37,727
10/22/2019	Amit Sachdev	EVP	Sell	3,883	$190.27	$738,818.41	37,299
10/22/2019	Jeffrey M. Leiden	CEO	Sell	107,831	$190.00	$20,487,890.00	178,707
10/22/2019	Margaret G. McGlynn	Director	Sell	20,000	$190.00	$3,800,000.00	24,124
10/22/2019	Reshma Kewalramani	CMO	Sell	638	$189.00	$120,582.00	13,098
10/17/2019	Michael Parini	EVP	Sell	4,250	$177.80	$755,650.00	39,253
10/14/2019	Michael Parini	EVP	Sell	2,125	$174.06	$369,877.50	37,128
10/2/2019	Sangeeta N Bhatia	Director	Sell	8,379	$166.80	$1,397,617.20	7,810
10/1/2019	Ourania Tatsis	SVP	Sell	188	$169.11	$31,792.68	7,696
8/19/2019	David Altshuler	EVP	Sell	12,501	$186.38	$2,329,936.38	35,803
8/13/2019	Margaret G. McGlynn	Director	Sell	10,000	$185.00	$1,850,000.00	14,124
8/8/2019	Stuart A. Arbuckle	EVP	Sell	2,125	$181.89	$386,516.25	35,365
8/5/2019	Michael Parini	EVP	Sell	2,330	$175.28	$408,402.40	34,395
8/2/2019	Stuart A. Arbuckle	EVP	Sell	2,155	$177.78	$383,115.90	34,395
7/12/2019	Michael Parini	EVP	Sell	2,125	$175.27	$372,448.75	37,128
7/5/2019	Michael Parini	EVP	Sell	4,250	$179.11	$761,217.50	39,253

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

89.84% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/30/2022	Amalgamated Bank	69,389	$18.11M	0.1%	-2.5%	0.027%
6/21/2022	Livforsakringsbolaget Skandia Omsesidigt	18,887	$4.93M	0.3%	+22.7%	0.007%
6/16/2022	Hellman Jordan Management Co. Inc. MA	4,866	$1.27M	1.4%	-37.5%	0.002%
6/14/2022	Offit Capital Advisors LLC	2,524	$0.66M	0.1%	+11.4%	0.001%
6/7/2022	Teachers Retirement System of The State of Kentucky	261,130	$68.15M	0.7%	+44.9%	0.102%
6/3/2022	Rehmann Capital Advisory Group	2,800	$0.75M	0.1%	+16.3%	0.001%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	324,500	$84.69M	0.2%	+13.8%	0.127%
5/27/2022	Walleye Capital LLC	12,740	$3.33M	0.1%	-59.2%	0.005%
5/26/2022	Kestra Private Wealth Services LLC	1,483	$0.39M	0.0%	-2.8%	0.001%
5/23/2022	Advisory Services Network LLC	4,275	$1.12M	0.0%	+123.9%	0.002%
5/23/2022	Neuberger Berman Group LLC	242,769	$63.36M	0.1%	0.0%	0.095%
5/20/2022	Sawtooth Solutions LLC	3,434	$0.90M	0.1%	+50.5%	0.001%
5/20/2022	International Biotechnology Trust PLC	25,122	$3.23M	0.7%	-67.5%	0.010%
5/20/2022	The Manufacturers Life Insurance Company	638,594	$165.93M	0.1%	+33.9%	0.250%
5/20/2022	Toroso Investments LLC	18,510	$4.83M	0.1%	N/A	0.007%
5/20/2022	Van Hulzen Asset Management LLC	77,300	$20.17M	2.1%	+10.6%	0.030%
5/19/2022	Capital World Investors	12,666,130	$3.31B	0.6%	+9.9%	4.952%
5/19/2022	Capital International Sarl	42,027	$10.97M	0.5%	-9.7%	0.016%
5/19/2022	Capital International Ltd. CA	63,256	$16.51M	0.9%	-24.3%	0.025%
5/19/2022	Capital Group International Inc. CA	60,056	$15.67M	0.2%	-44.0%	0.023%
5/19/2022	Capital International Investors	125,595	$32.78M	0.0%	-93.8%	0.049%
5/19/2022	Capital Group Private Client Services Inc.	57,226	$14.93M	0.2%	+0.1%	0.022%
5/19/2022	Orion Portfolio Solutions LLC	1,815	$0.47M	0.0%	-17.3%	0.001%
5/18/2022	BNP Paribas Arbitrage SA	268,469	$70.06M	0.1%	+58.2%	0.105%
5/18/2022	Gabelli Funds LLC	37,962	$9.91M	0.1%	+21.3%	0.015%
5/17/2022	Walleye Capital LLC	12,740	$3.33M	0.1%	-59.2%	0.005%
5/17/2022	Wealthfront Advisers LLC	15,359	$4.01M	0.0%	+115.6%	0.006%
5/17/2022	Heirloom Wealth Management	10,946	$2.70M	1.9%	-2.3%	0.004%
5/17/2022	Cim Investment Management Inc.	1,374	$0.36M	0.1%	-90.5%	0.001%
5/17/2022	Advisors Asset Management Inc.	15,866	$4.14M	0.1%	-25.3%	0.006%
5/17/2022	Mirabella Financial Services LLP	2,449	$0.64M	0.1%	N/A	0.001%
5/17/2022	KB Financial Partners LLC	1,235	$0.32M	0.1%	+8.6%	0.000%
5/17/2022	Lido Advisors LLC	4,055	$1.06M	0.0%	+21.3%	0.002%
5/17/2022	Carolinas Wealth Consulting LLC	251	$66K	0.0%	-19.0%	0.000%
5/17/2022	MidWestOne Financial Group Inc.	5,210	$1.36M	0.3%	-23.7%	0.002%
5/17/2022	Meiji Yasuda Asset Management Co Ltd.	22,122	$5.77M	0.3%	-4.7%	0.009%
5/17/2022	Meiji Yasuda Life Insurance Co	6,522	$1.70M	0.0%	-13.9%	0.003%
5/17/2022	Davidson Capital Management Inc.	6,610	$1.73M	0.6%	+32.0%	0.003%
5/17/2022	SkyView Investment Advisors LLC	1,330	$0.35M	0.1%	-91.8%	0.001%
5/17/2022	Beacon Pointe Advisors LLC	27,932	$7.29M	0.1%	+24.0%	0.011%
5/17/2022	Kiwi Wealth Investments Limited Partnership	13,697	$3.58M	0.2%	N/A	0.005%
5/17/2022	Point72 Hong Kong Ltd	183	$48K	0.0%	-98.6%	0.000%
5/17/2022	Polar Capital Holdings Plc	300,280	$78.36M	0.4%	-19.9%	0.117%
5/17/2022	Provident Investment Management Inc.	187,314	$48.88M	4.7%	+1.2%	0.073%
5/17/2022	Quantbot Technologies LP	401	$0.10M	0.0%	N/A	0.000%
5/17/2022	Royal Bank of Canada	840,095	$219.24M	0.1%	+19.4%	0.328%
5/17/2022	Donoghue Forlines LLC	3,228	$0.84M	0.2%	N/A	0.001%
5/17/2022	Eaton Vance Management	444,509	$116M	0.1%	+14.3%	0.174%
5/17/2022	Evergreen Capital Management LLC	1,169	$0.31M	0.0%	+24.6%	0.000%
5/17/2022	Endurant Capital Management LP	6,982	$1.82M	0.5%	N/A	0.003%
5/17/2022	Ensign Peak Advisors Inc	333,309	$86.99M	0.2%	+12.7%	0.130%
5/17/2022	Eqis Capital Management Inc.	5,089	$1.33M	0.1%	+8.1%	0.002%
5/17/2022	First Republic Investment Management Inc.	33,106	$8.64M	0.0%	+8.8%	0.013%
5/17/2022	Forum Financial Management LP	1,689	$0.44M	0.0%	-4.3%	0.001%
5/17/2022	Guardian Wealth Advisors LLC NC	1,015	$0.27M	0.1%	N/A	0.000%
5/17/2022	Guggenheim Capital LLC	220,611	$57.57M	0.3%	+4.2%	0.086%
5/17/2022	Geneos Wealth Management Inc.	445	$0.12M	0.0%	+36.9%	0.000%
5/17/2022	2Xideas AG	71,765	$18.73M	1.3%	-10.5%	0.028%
5/16/2022	Power Corp of Canada	3,808	$0.99M	0.1%	N/A	0.001%
5/16/2022	California State Teachers Retirement System	429,177	$112M	0.1%	-7.0%	0.168%
5/16/2022	PDT Partners LLC	24,800	$6.47M	0.6%	+1.2%	0.010%
5/16/2022	Captrust Financial Advisors	19,438	$5.07M	0.0%	+16.5%	0.008%
5/16/2022	IHT Wealth Management LLC	1,838	$0.48M	0.0%	-56.9%	0.001%
5/16/2022	Allstate Corp	18,874	$4.93M	0.1%	-1.1%	0.007%
5/16/2022	Brinker Capital Investments LLC	13,381	$3.49M	0.1%	-0.3%	0.005%
5/16/2022	Woodline Partners LP	74,671	$19.49M	0.3%	-28.0%	0.029%
5/16/2022	Wellington Management Group LLP	8,053,710	$2.10B	0.4%	+23.6%	3.149%
5/16/2022	Resurgent Financial Advisors LLC	1,337	$0.35M	0.2%	N/A	0.001%
5/16/2022	Wetherby Asset Management Inc.	5,653	$1.48M	0.1%	+8.1%	0.002%
5/16/2022	State Street Corp	12,052,763	$3.15B	0.2%	-2.5%	4.713%
5/16/2022	Ethic Inc.	2,349	$0.61M	0.0%	+7.2%	0.001%
5/16/2022	Samalin Investment Counsel LLC	475	$0.12M	0.1%	-12.0%	0.000%
5/16/2022	Prelude Capital Management LLC	6,587	$1.72M	0.0%	+96.6%	0.003%
5/16/2022	J. Goldman & Co LP	11,970	$3.12M	0.1%	-6.2%	0.005%
5/16/2022	Harding Loevner LP	1,769,276	$417.34M	2.3%	-6.0%	0.692%
5/16/2022	Engineers Gate Manager LP	7,264	$1.90M	0.1%	-26.9%	0.003%
5/16/2022	United Capital Financial Advisers LLC	1,246	$0.33M	0.0%	-17.0%	0.000%
5/16/2022	Cresset Asset Management LLC	3,007	$0.79M	0.0%	+17.7%	0.001%
5/16/2022	Vident Investment Advisory LLC	41,454	$10.82M	0.3%	+37.6%	0.016%
5/16/2022	Horizon Investments LLC	11,370	$2.97M	0.1%	+20.1%	0.004%
5/16/2022	Atria Wealth Solutions Inc.	6,026	$1.57M	0.0%	N/A	0.002%
5/16/2022	Capital Group Private Client Services Inc.	57,226	$14.93M	0.2%	+0.1%	0.022%
5/16/2022	Myriad Asset Management Ltd.	14,100	$3.68M	0.5%	+35.6%	0.006%
5/16/2022	Graham Capital Management L.P.	2,659	$0.69M	0.0%	+9.2%	0.001%
5/16/2022	Personal Capital Advisors Corp	831	$0.22M	0.0%	-27.3%	0.000%
5/16/2022	Invesco Ltd.	1,210,357	$315.87M	0.1%	+7.9%	0.473%
5/16/2022	Achmea Investment Management B.V.	36,132	$9.43M	0.2%	N/A	0.014%
5/16/2022	PFS Investments Inc.	56,891	$14.85M	0.3%	-17.3%	0.022%
5/16/2022	Williams Jones Wealth Management LLC.	1,046	$0.27M	0.0%	+5.7%	0.000%
5/13/2022	Silverarc Capital Management LLC	7,638	$1.99M	0.8%	+52.8%	0.003%
5/13/2022	Rhenman & Partners Asset Management AB	89,500	$23.36M	2.3%	-45.8%	0.035%
5/13/2022	SVB Wealth LLC	16,868	$4.40M	0.1%	+3.0%	0.007%
5/13/2022	Ameritas Investment Partners Inc.	17,306	$4.52M	0.2%	-0.9%	0.007%
5/13/2022	Renaissance Technologies LLC	1,707,368	$445.57M	0.5%	+4.9%	0.668%
5/13/2022	Bellevue Group AG	1,480,253	$386.30M	4.5%	-17.4%	0.579%
5/13/2022	Ontario Teachers Pension Plan Board	5,222	$1.36M	0.0%	N/A	0.002%
5/13/2022	Northern Trust Corp	2,889,953	$754.19M	0.1%	-0.6%	1.130%
5/13/2022	Industrial Alliance Investment Management Inc.	43,002	$11.22M	0.3%	-9.7%	0.017%
5/13/2022	ING Groep NV	11,181	$2.92M	0.0%	-74.6%	0.004%
5/13/2022	Charles Schwab Investment Management Inc.	1,327,466	$346.43M	0.1%	+5.2%	0.519%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $287.32

$279.55

$287.66

50 Day Range

MA: $265.14

$234.96

$292.55

52 Week Range

Now: $287.32

$176.36

$293.17

Volume

46,392 shs

Average Volume

1,737,818 shs

Market Capitalization

$73.48 billion

P/E Ratio

30.24

Dividend Yield

N/A

Beta

0.5

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Reshma Kewalramani (CEO)
Jeffrey M Leiden (Chairman)
Stuart A Arbuckle (COO)
Michael Parini (EVP)
Amit Sachdev (EVP)
Charles F Wagner Jr (CFO)
Bastiano Sanna (EVP)
Stuart A Arbuckle (EVP)
Paul M Silva (CAO)
Bruce I Sachs (Director)
Paul M Silva (SVP)
Sangeeta N Bhatia (Director)
Joy Liu (SVP)
Sangeeta N Bhatia (Director)
Kristen Ambrose (CAO)
Yuchun Lee (Director)
Margaret G Mcglynn (Director)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Learn More about top insider investors at Vertex Pharmaceuticals.

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

VRTX Insider Trading (Vertex Pharmaceuticals)

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

Vertex Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?